[HTML][HTML] Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications

F Zahedipour, F Zahedipour, P Zamani, MR Jaafari… - Virus Research, 2024 - Elsevier
The CRISPR/Cas system, identified as a type of bacterial adaptive immune system, have
attracted significant attention due to its remarkable ability to precisely detect and eliminate …